Skip to content
Research Article Open access CC BY 4.0

New Combined Drug Regimen for Complete Cure of Pulmonary Tuberculosis in Patient with Impaired Hepatocellular Functioning – A Case Report

Soham Samajpaty, Gulnaz Minegalievna Ibragimova

International Journal of TROPICAL DISEASE & Health · pp. 31–38 · Published 11 Nov 2022

10.9734/ijtdh/2022/v43i221365

Abstract

The research gives new therapeutic regimen to Tuberculosis. Despite of the fact being that the current regimen is a burden on liver functioning; most of these are highly hepatotoxic and increases serum alanine aminotransferase (ALT) manifolds. In the backdrop of such a condition this clinical study has been done. Here 4 drugs has been selected and TB infection of a middle aged female patient was cured rapidly in one month who had hepatocellular changes. The regimen in this research has also showed significant improvement of liver functions post-therapy. This is about the “Mumbai Protocol” of tuberculosis management.

Tuberculosis Mycobacterium tuberculosis Mumbai protocol infection therapy

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

14

Page views

0

PDF downloads

2

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.